Recruiting
Phase 3

RSV Vaccine in Transplant Recipients

Sponsor:

University Health Network, Toronto

Code:

NCT06593210

Conditions

Vaccine Response Impaired

Respiratory Syncytial Virus Infections

Immune Suppression

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Adjuvant, non-live RSV vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2025-03-25.